Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

Filed under: News |

LONDON (Reuters) – Shire , the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical , is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion.



List your business in the premium web directory for free This website is listed under Human Resources Directory